Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Journals’ Impact Factor Remains Strong

04 Jul 2023

According to the 2023 Journal Citation Reports, the Impact Factor (IF) of ESMO Journals remains strong this year. Contributing to shape the oncology field by disseminating high-quality science and promoting discussions on cutting-edge topics, Annals of Oncology-Driving Innovation in Oncology, is now the 5th-ranked journal in oncology, with an IF of 50.5.

ESMO Open-Science for Optimal Cancer Care boasts an increased IF of 7.3, continuing to grow as an influential journal dedicated to publishing high-quality medical research and educational content from all disciplines in oncology, with a focus on innovative clinical and translational cancer research.

Two new editors-in-chief will be leading the journals as of January 2024: Tom Powles will be the new Editor-in-Chief of Annals of Oncology and Giuseppe Curigliano will take over ESMO Open.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.